Developer docs
API playgroundTry for free, no card

Search company profiles

XACT Robotics

Full company profile

uuid0002frt

Namestring
XACT Robotics
Legal namestring
XACT Robotics Ltd. and/or XACT Robotics Inc.
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCaesarea, Israel
HQ citystring
Caesarea
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
robotic needle steering, image-guided interventions, percutaneous procedures, interventional radiology, medical robotics systems
Industry4 codes
1Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryYes
2Healthcare & Assistive Robotics
CodeHDAAAIACPrimaryNo
3Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
CodeHLAHADAGPrimaryNo
4Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Robotics / Image-Guided Surgical Robotics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1XACT ACE Robotic System Sales
TypeHardware Sales
Description

Sale of the XACT ACE Robotic System to hospitals and medical facilities. The system is instrument agnostic, designed to utilize instruments already stocked at facilities, eliminating need for additional instrument purchases from XACT.

xactrobotics.com
2Service and Support
TypeProfessional Services
Description

Field service and customer support for installed systems including installation, repair, service, maintenance, and enhancement of hardware and software products.

xactrobotics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1XACT ACE Robotic System - enterprise medical device
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Available for purchase in U.S. and EMEA regions.

xactrobotics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1XACT ACE Robotic System
Description

The world's first and only comprehensive robotic system that combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive technology for percutaneous procedures.

xactrobotics.com
+2 more records
Core offering1 text field

XACT Robotics develops and manufactures the XACT ACE Robotic System, a hands-free robotic platform for CT-guided percutaneous procedures such as biopsy, ablation, drainage, and drug delivery. The system combines image-guided planning software, real-time CT monitoring, and the patented S-Drive non-linear steering technology to insert instruments with sub-1.7mm tip-to-target accuracy. The system is sold to hospitals and interventional radiology departments in the U.S. and EMEA.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Average tip-to-target accuracy of <1.7mm based on company clinical studies for biopsy procedures
+4 more records
Product overview1 text field

XACT Robotics offers the XACT ACE® Robotic System as its core product - the world's first and only comprehensive hands-free robotic system for CT-guided percutaneous procedures. The system integrates image-guided planning and real-time monitoring with patented S-Drive™ technology for non-linear instrument steering. An add-on module, ACE Xtend™ Remote Control Unit, enables remote operation from the control room. The system supports multiple clinical applications including biopsy, ablation, drainage, and drug delivery across various anatomies such as lungs, liver, kidneys, lymph nodes, and prostate.

Product and service3 records
1XACT ACE Robotic System
CategoryMedical Robotics / Interventional Radiology Capital Equipment
Description

The world's first and only comprehensive hands-free robotic system integrating image-guided planning, real-time monitoring, and precise robotic insertion with patented S-Drive non-linear steering for CT-guided percutaneous procedures. Sold to hospitals and interventional radiology departments for biopsy, ablation, drainage, and drug delivery applications.

2ACE Xtend Remote Control Unit
CategoryMedical Robotics Add-On / Remote Control Module
Description

FDA-cleared remote control unit that adds remote operation capability to the XACT ACE Robotic System, allowing users to robotically insert and steer instruments from the control room rather than at the procedure table. Improves physician workflows while limiting radiation exposure.

3Ablation Procedures Support Expansion (FDA-cleared indication expansion for XACT ACE)
CategoryMedical Robotics Indication Expansion / Software-Enabled Clinical Application
Description

An FDA-cleared indication expansion of the XACT ACE Robotic System that adds support for robotic insertion and steering of ablation probes during percutaneous ablation procedures, expanding the addressable clinical applications of the system.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-01
Description

XACT Robotics is a distinguished corporate member of the SIR Corporate Ambassador Program. The program provides forward-thinking companies with opportunities for strategic collaboration with the ultimate goal of advancing interventional radiology and informing the future of the specialty.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-01
Description

Completed world's first remote controlled robotic instrument insertion and non-linear steering during an interventional oncology percutaneous procedure using ACE Xtend remote control feature. Validated ability to control system from outside procedure room for radiation protection.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-08-01
Description

Private practice interventional radiology group that completed over 100 hands-free procedures using the XACT system. Dr. Gerald Grubbs performed the world's first remote controlled robotic instrument insertion with ACE Xtend. Contributed significant clinical validation data.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Major Israeli medical center that participated in clinical validation of the XACT ACE Robotic System as part of the multi-center case milestone.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-11-01
Description

Major teaching hospital in Massachusetts acquired the XACT ACE Robotic System, becoming the first hospital in the U.S. to offer robotic percutaneous radiology procedures. Lahey participated in clinical research demonstrating system efficacy leading to FDA approval, with Dr. Sebastian Flacke serving as Chief of Interventional Radiology.

Strategic tierFoundationalTypeTechnology or IntegrationAnnounced on2019-01-01
Description

XACT Robotics technology is based on research originally conducted at the Technion - Israel Institute of Technology by Prof. Moshe Shoham, founder of Mazor Robotics (acquired by Medtronic in 2018). This academic origin provided the foundational technology platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Market leader in surgical robotics with the da Vinci platform. While focused on laparoscopic and thoracic surgery, Intuitive has the resources and hospital relationships to expand into image-guided percutaneous procedures, making it a broad incumbent threat to XACT's niche.

TypeBroad incumbent
Description

Acquired Mazor Robotics (founded by Prof. Moshe Shoham, the same researcher behind XACT's technology roots) for spine robotics. Medtronic's installed base and commercial reach in hospitals make it a major surgical robotics incumbent that could expand into percutaneous applications.

TypeBroad incumbent
Description

MAKO robotic-arm assisted surgery platform dominates orthopedic robotics. Stryker's commercial scale and capital equipment relationships with hospitals position it as a broad incumbent that could potentially enter the percutaneous imaging-guided robotics space.

TypeBroad incumbent
Description

Acquired Corindus Vascular Robotics for endovascular robotic procedures. Siemens has the imaging modality expertise and global hospital footprint to expand into broader image-guided percutaneous robotics, creating direct adjacency to XACT's space.

TypeDirect peer
Description

Developer of the NeuroBlate system, an MRI-guided robotic laser ablation platform for neurosurgery. Shares XACT's ablation-procedure focus and robotic image-guided positioning, though limited to neurosurgical applications.

TypeDirect peer
Description

Provides image-guided surgery platforms and surgical navigation software used in percutaneous and image-guided interventions. Overlaps with XACT in imaging integration and procedural planning workflows, and competes for hospital capital budgets.

TypeDirect peer
Description

J&J's robotic surgery subsidiary developing the Monarch platform for bronchoscopy and lung procedures. Directly overlaps with XACT's lung procedure capability and is backed by J&J's hospital sales force and capital.

TypeDirect peer
Description

Manufactures the Neuromate and Rosa surgical robots for neurosurgical and spinal procedures. Shares the image-guided robotic surgery category with XACT, though focused on cranial and spinal applications.

TypeDirect peer
Description

Develops robotic systems for orthopedic surgery, including the TSolution One platform. Competes for hospital capital equipment budgets and shares the surgical robotics category with XACT.

TypeDirect peer
Description

Develops the ExcelsiusGPS robotic navigation platform for spine surgery. A direct competitor in image-guided surgical robotics with an established hospital sales channel and broader product portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

XACT Robotics

Medical Robotics / Image-Guided Surgical Roboticsxactrobotics.com

XACT Robotics firmographics

Firmographics
Name
XACT Robotics
Legal name
XACT Robotics Ltd. and/or XACT Robotics Inc.
Website
https://xactrobotics.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

XACT Robotics industry classification

Industry
Product category
Medical Robotics / Image-Guided Surgical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
akta.pro secondary industries
Healthcare & Assistive Robotics (HDAAAIAC), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

  • Robotic needle steering
  • Image-guided interventions
  • Percutaneous procedures
  • Interventional radiology
  • Medical robotics systems

Where XACT Robotics is headquartered

Location

Headquarters

HQ city
Caesarea
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

XACT Robotics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. XACT ACE Robotic System Sales: Sale of the XACT ACE Robotic System to hospitals and medical facilities. The system is instrument agnostic, designed to utilize instruments already stocked at facilities, eliminating need for additional instrument purchases from XACT.
  2. Service and Support: Field service and customer support for installed systems including installation, repair, service, maintenance, and enhancement of hardware and software products.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractXACT ACE Robotic System - enterprise medical device

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

XACT Robotics product offering

Product offering

Core offering

XACT Robotics develops and manufactures the XACT ACE Robotic System, a hands-free robotic platform for CT-guided percutaneous procedures such as biopsy, ablation, drainage, and drug delivery. The system combines image-guided planning software, real-time CT monitoring, and the patented S-Drive non-linear steering technology to insert instruments with sub-1.7mm tip-to-target accuracy. The system is sold to hospitals and interventional radiology departments in the U.S. and EMEA.

Product overview

XACT Robotics offers the XACT ACE® Robotic System as its core product - the world's first and only comprehensive hands-free robotic system for CT-guided percutaneous procedures. The system integrates image-guided planning and real-time monitoring with patented S-Drive™ technology for non-linear instrument steering. An add-on module, ACE Xtend™ Remote Control Unit, enables remote operation from the control room. The system supports multiple clinical applications including biopsy, ablation, drainage, and drug delivery across various anatomies such as lungs, liver, kidneys, lymph nodes, and prostate.

Differentiator

Problem solved

Functional benefit

Brands

  • XACT ACE Robotic System: The world's first and only comprehensive robotic system that combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive technology for percutaneous procedures.
  • S-Drive Technology
  • ACE Xtend Remote Control Unit

Products and services

  • XACT ACE Robotic System The world's first and only comprehensive hands-free robotic system integrating image-guided planning, real-time monitoring, and precise robotic insertion with patented S-Drive non-linear steering for CT-guided percutaneous procedures. Sold to hospitals and interventional radiology departments for biopsy, ablation, drainage, and drug delivery applications.
  • ACE Xtend Remote Control Unit FDA-cleared remote control unit that adds remote operation capability to the XACT ACE Robotic System, allowing users to robotically insert and steer instruments from the control room rather than at the procedure table. Improves physician workflows while limiting radiation exposure.
  • Ablation Procedures Support Expansion (FDA-cleared indication expansion for XACT ACE) An FDA-cleared indication expansion of the XACT ACE Robotic System that adds support for robotic insertion and steering of ablation probes during percutaneous ablation procedures, expanding the addressable clinical applications of the system.

Quantifiable outcome

  • Average tip-to-target accuracy of <1.7mm based on company clinical studies for biopsy procedures
  • +4 more outcomes

Companies that use XACT Robotics

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles1 record

XACT Robotics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

XACT Robotics partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and foundational.

  • Society of Interventional Radiology (SIR)coreStrategic or Co-development Partner · 1 June 2022XACT Robotics is a distinguished corporate member of the SIR Corporate Ambassador Program. The program provides forward-thinking companies with opportunities for strategic collaboration with the ultimate goal of advancing interventional radiology and informing the future of the specialty.
  • Sarasota Interventional RadiologycoreStrategic or Co-development Partner · 1 October 2021Completed world's first remote controlled robotic instrument insertion and non-linear steering during an interventional oncology percutaneous procedure using ACE Xtend remote control feature. Validated ability to control system from outside procedure room for radiation protection.
  • Sarasota Interventional RadiologycoreStrategic or Co-development Partner · 1 August 2021Private practice interventional radiology group that completed over 100 hands-free procedures using the XACT system. Dr. Gerald Grubbs performed the world's first remote controlled robotic instrument insertion with ACE Xtend. Contributed significant clinical validation data.
  • Hadassah Medical CentercoreStrategic or Co-development Partner · 1 January 2021Major Israeli medical center that participated in clinical validation of the XACT ACE Robotic System as part of the multi-center case milestone.
  • Lahey Hospital & Medical CentercoreStrategic or Co-development Partner · 1 November 2020Major teaching hospital in Massachusetts acquired the XACT ACE Robotic System, becoming the first hospital in the U.S. to offer robotic percutaneous radiology procedures. Lahey participated in clinical research demonstrating system efficacy leading to FDA approval, with Dr. Sebastian Flacke serving as Chief of Interventional Radiology.
  • Technion - Israel Institute of TechnologyfoundationalTechnology or Integration · 1 January 2019XACT Robotics technology is based on research originally conducted at the Technion - Israel Institute of Technology by Prof. Moshe Shoham, founder of Mazor Robotics (acquired by Medtronic in 2018). This academic origin provided the foundational technology platform.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

XACT Robotics competitors and assessment

Company assessment

Broad incumbents

  • Intuitive Surgical: Market leader in surgical robotics with the da Vinci platform. While focused on laparoscopic and thoracic surgery, Intuitive has the resources and hospital relationships to expand into image-guided percutaneous procedures, making it a broad incumbent threat to XACT's niche.
  • Medtronic (Mazor Robotics): Acquired Mazor Robotics (founded by Prof. Moshe Shoham, the same researcher behind XACT's technology roots) for spine robotics. Medtronic's installed base and commercial reach in hospitals make it a major surgical robotics incumbent that could expand into percutaneous applications.
  • Stryker (MAKO Surgical): MAKO robotic-arm assisted surgery platform dominates orthopedic robotics. Stryker's commercial scale and capital equipment relationships with hospitals position it as a broad incumbent that could potentially enter the percutaneous imaging-guided robotics space.
  • Siemens Healthineers (Corindus): Acquired Corindus Vascular Robotics for endovascular robotic procedures. Siemens has the imaging modality expertise and global hospital footprint to expand into broader image-guided percutaneous robotics, creating direct adjacency to XACT's space.

Direct peers

  • Monteris Medical: Developer of the NeuroBlate system, an MRI-guided robotic laser ablation platform for neurosurgery. Shares XACT's ablation-procedure focus and robotic image-guided positioning, though limited to neurosurgical applications.
  • Brainlab: Provides image-guided surgery platforms and surgical navigation software used in percutaneous and image-guided interventions. Overlaps with XACT in imaging integration and procedural planning workflows, and competes for hospital capital budgets.
  • Auris Health (Johnson & Johnson): J&J's robotic surgery subsidiary developing the Monarch platform for bronchoscopy and lung procedures. Directly overlaps with XACT's lung procedure capability and is backed by J&J's hospital sales force and capital.
  • Renishaw: Manufactures the Neuromate and Rosa surgical robots for neurosurgical and spinal procedures. Shares the image-guided robotic surgery category with XACT, though focused on cranial and spinal applications.
  • THINK Surgical: Develops robotic systems for orthopedic surgery, including the TSolution One platform. Competes for hospital capital equipment budgets and shares the surgical robotics category with XACT.
  • Globus Medical (ExcelsiusGPS): Develops the ExcelsiusGPS robotic navigation platform for spine surgery. A direct competitor in image-guided surgical robotics with an established hospital sales channel and broader product portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

XACT Robotics social profiles

Digital presence

XACT Robotics compliance and trust

Trust signal

Compliance4 records

XACT Robotics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

XACT Robotics leadership team

Management profile

Number of profiles

Profiles16 records

XACT Robotics funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

XACT Robotics M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about XACT Robotics

What does XACT Robotics do?

XACT Robotics develops and manufactures the XACT ACE Robotic System, a hands-free robotic platform for CT-guided percutaneous procedures such as biopsy, ablation, drainage, and drug delivery. The system combines image-guided planning software, real-time CT monitoring, and the patented S-Drive non-linear steering technology to insert instruments with sub-1.7mm tip-to-target accuracy. The system is sold to hospitals and interventional radiology departments in the U.S. and EMEA.

Is XACT Robotics a public or private company?

XACT Robotics is a private company. It is classified as venture growth investor backed and is currently operating.

When was XACT Robotics founded?

XACT Robotics was founded in 2013. It employs 51 to 100 people.

Where is XACT Robotics based?

XACT Robotics is headquartered in Caesarea, Israel, in the Middle East region.

How does XACT Robotics make money?

Two revenue lines are on record. XACT ACE Robotic System Sales are the primary driver. The others are service and Support.

Who are XACT Robotics's main competitors?

Broad incumbents on record are Intuitive Surgical, Medtronic (Mazor Robotics), Stryker (MAKO Surgical) and Siemens Healthineers (Corindus). Direct peers are Monteris Medical, Brainlab, Auris Health (Johnson & Johnson), Renishaw, THINK Surgical and Globus Medical (ExcelsiusGPS).

Does XACT Robotics have an API?

No public API is recorded for XACT Robotics.

What industry is XACT Robotics in?

XACT Robotics's product category is Medical Robotics / Image-Guided Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireInterventional Oncology Devices Market Analysis Shows 9% Growth Rate Through 2026The Business Research Company released a market analysis forecasting the global interventional oncology devices market to grow from $1.97 billion in 2021 to $3.03 billion by 2026, representing a compound annual growth rate of approximately 9%. North America dominated the market in 2021 with a 35.6% share, while Asia Pacific and South America are projected to be the fastest-growing regions. The report identifies emerging trends including robotics technology adoption, with companies such as Quantum Surgical and XACT Robotics introducing new robotic-assisted systems for tumor ablation and CT-guided procedures.PR NewswireXACT Robotics® Lauded by Frost & Sullivan for Improving CT-guided Percutaneous Procedures with Its Breakthrough Hands-Free Robotic SystemFrost & Sullivan recognized XACT Robotics with the 2021 North American Percutaneous Procedure System Technology Innovation Leadership Award for its XACT ACE Robotic System, which addresses limitations of manual CT-guided percutaneous procedures. The system achieves sub-1.7mm accuracy and reaches target sites in under 8.5 minutes with a single insertion, while reducing radiation exposure for medical staff and improving procedure efficiency. The award highlights the system's potential to reduce reliance on physicians' technical skills and enable broader use of percutaneous procedures across different healthcare settings.GlobeNewswireXACT Robotics® Makes History: Announces the First EverXACT Robotics announced the world's first remote-controlled robotic instrument insertion and non-linear steering during an interventional oncology percutaneous procedure using ACE Xtend. The procedure was performed by Sarasota Interventional Radiology, and the system has been proven in over 200 clinical and pre-clinical cases.PR NewswireXACT Robotics® Appoints New Vice President, Sales and MarketingXACT Robotics announced the appointment of Christopher Horton as Vice President of Sales and Marketing to lead commercial expansion of the XACT ACE™ Robotic System, the world's first hands-free robotic technology for CT-guided percutaneous procedures. Horton brings nearly 30 years of medical device industry experience, most recently serving as Regional Vice President of Sales at Merit Medical managing sales operations across 23 states. The company, founded in 2013 and headquartered in Hingham, Massachusetts with an additional office in Caesarea, Israel, holds FDA clearance and CE Mark approval for the system.PR NewswireXACT Robotics Announces Completion of Enrollment in Pilot Trial Evaluating Use of its Robotic System to Perform CT-Guided Percutaneous Procedures in the LungXACT Robotics announced completion of patient enrollment in the first U.S. pilot trial evaluating its XACT ACE™ Robotic System for CT-guided percutaneous lung procedures including biopsies, with Lahey Hospital & Medical Center and Sarasota Interventional Radiology serving as trial sites. The robotic system is designed to help radiologists reach small areas of interest in the lung with high accuracy in a single insertion, potentially enabling earlier diagnosis and treatment of lung cancer. The trial primarily evaluated safety and accuracy metrics, with the system demonstrating the ability to steer and adjust insertion pathways even when target areas move during procedures.PR NewswireXACT Robotics Announces Successful Completion of over 100 "Hands-free" Percutaneous Procedures Using Its Robotic SystemXACT Robotics announced that its robotic system has been used in over 100 percutaneous procedures at Lahey Hospital & Medical Center, Sarasota Interventional Radiology, and Hadassah Medical Center in the U.S. and Israel. The company claims its system is the world's first and only hands-free robotic technology combining image-based planning with robotic instrument insertion and steering, enabling physicians to reach small targets in the abdomen and lung with improved accuracy on the first attempt even when targets shift.GlobeNewswireFierceMedTech names XACT Robotics as one of its “Fierce 15” companies of 2019XACT Robotics was named to FierceMedTech's 2019 Fierce 15 list, recognizing it as a promising private medtech company. Its hands-free robotic system is cleared for CT-guided percutaneous interventional procedures in the U.S. and EU. The company aims to democratize interventional procedures.FinSMEsXact Robotics Closes $5M in Series C FundingXact Robotics, an Israeli developer of robotic navigation for percutaneous procedures, raised $5M in Series C funding. The company will use the funds to launch seven Centers of Excellence in the US, Europe, and Israel, expecting hundreds of procedures within 12 months. The system has CE Mark approval and is expected to expand to additional imaging modalities and indications later this year.PR NewswireXACT Robotics Receives CE Mark for Its Robotics Navigation System for Percutaneous ProceduresXACT Robotics announced it received CE Mark approval for its robotic navigation and steering system used in image-guided percutaneous procedures. The company also secured $5 million in Series C investment to fund the launch of seven Centers of Excellence across the US, Europe, and Israel. These centers aim to gather clinical experience and train physicians ahead of a full product launch planned for 2019.